Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TBX21
|
ENSG00000073861.2 | T-box transcription factor 21 |
TBR1
|
ENSG00000136535.10 | T-box brain transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TBX21 | hg19_v2_chr17_+_45810594_45810610 | -0.42 | 2.0e-02 | Click! |
TBR1 | hg19_v2_chr2_+_162272605_162272753 | 0.29 | 1.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_94727048 | 15.32 |
ENST00000283357.5
|
FAM81B
|
family with sequence similarity 81, member B |
chr1_+_38022572 | 14.19 |
ENST00000541606.1
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
chr1_+_38022513 | 12.62 |
ENST00000296218.7
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
chr11_+_73358594 | 10.39 |
ENST00000227214.6
ENST00000398494.4 ENST00000543085.1 |
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr19_-_7990991 | 8.56 |
ENST00000318978.4
|
CTXN1
|
cortexin 1 |
chr5_-_35938674 | 6.62 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
chr4_-_177116772 | 6.41 |
ENST00000280191.2
|
SPATA4
|
spermatogenesis associated 4 |
chr2_+_228736321 | 5.24 |
ENST00000309931.2
|
DAW1
|
dynein assembly factor with WDR repeat domains 1 |
chr7_-_120497178 | 5.12 |
ENST00000441017.1
ENST00000424710.1 ENST00000433758.1 |
TSPAN12
|
tetraspanin 12 |
chr3_-_66551397 | 4.89 |
ENST00000383703.3
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
chr11_+_6260298 | 4.85 |
ENST00000379936.2
|
CNGA4
|
cyclic nucleotide gated channel alpha 4 |
chr2_+_228736335 | 4.75 |
ENST00000440997.1
ENST00000545118.1 |
DAW1
|
dynein assembly factor with WDR repeat domains 1 |
chr3_-_66551351 | 4.67 |
ENST00000273261.3
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
chr3_-_100712352 | 4.44 |
ENST00000471714.1
ENST00000284322.5 |
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
chr16_-_67450325 | 3.94 |
ENST00000348579.2
|
ZDHHC1
|
zinc finger, DHHC-type containing 1 |
chr13_-_39564993 | 3.55 |
ENST00000423210.1
|
STOML3
|
stomatin (EPB72)-like 3 |
chr12_+_69742121 | 3.46 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
chr5_+_140571902 | 3.41 |
ENST00000239446.4
|
PCDHB10
|
protocadherin beta 10 |
chr17_-_56406117 | 3.39 |
ENST00000268893.6
ENST00000355701.3 |
BZRAP1
|
benzodiazepine receptor (peripheral) associated protein 1 |
chr19_+_36236514 | 3.36 |
ENST00000222266.2
|
PSENEN
|
presenilin enhancer gamma secretase subunit |
chr19_+_36236491 | 3.33 |
ENST00000591949.1
|
PSENEN
|
presenilin enhancer gamma secretase subunit |
chr1_+_47264711 | 3.25 |
ENST00000371923.4
ENST00000271153.4 ENST00000371919.4 |
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1 |
chr17_+_35849937 | 2.99 |
ENST00000394389.4
|
DUSP14
|
dual specificity phosphatase 14 |
chr14_+_95078714 | 2.97 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr8_+_75896731 | 2.79 |
ENST00000262207.4
|
CRISPLD1
|
cysteine-rich secretory protein LCCL domain containing 1 |
chr1_+_212782012 | 2.66 |
ENST00000341491.4
ENST00000366985.1 |
ATF3
|
activating transcription factor 3 |
chr7_-_138386097 | 2.56 |
ENST00000421622.1
|
SVOPL
|
SVOP-like |
chrX_+_53449887 | 2.54 |
ENST00000375327.3
|
RIBC1
|
RIB43A domain with coiled-coils 1 |
chr2_-_157189180 | 2.52 |
ENST00000539077.1
ENST00000424077.1 ENST00000426264.1 ENST00000339562.4 ENST00000421709.1 |
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
chr1_-_26633067 | 2.47 |
ENST00000421827.2
ENST00000374215.1 ENST00000374223.1 ENST00000357089.4 ENST00000535108.1 ENST00000314675.7 ENST00000436301.2 ENST00000423664.1 ENST00000374221.3 |
UBXN11
|
UBX domain protein 11 |
chr22_+_31003133 | 2.45 |
ENST00000405742.3
|
TCN2
|
transcobalamin II |
chr1_-_46598371 | 2.45 |
ENST00000372006.1
ENST00000425892.1 ENST00000420542.1 ENST00000354242.4 ENST00000340332.6 |
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
chr22_+_31003190 | 2.42 |
ENST00000407817.3
|
TCN2
|
transcobalamin II |
chr1_-_46598284 | 2.34 |
ENST00000423209.1
ENST00000262741.5 |
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
chr16_+_30212378 | 2.30 |
ENST00000569485.1
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 |
chr9_-_75567962 | 2.26 |
ENST00000297785.3
ENST00000376939.1 |
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1 |
chr11_-_47736896 | 2.22 |
ENST00000525123.1
ENST00000528244.1 ENST00000532595.1 ENST00000529154.1 ENST00000530969.1 |
AGBL2
|
ATP/GTP binding protein-like 2 |
chr12_+_56473939 | 2.21 |
ENST00000450146.2
|
ERBB3
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
chr9_+_26956371 | 2.11 |
ENST00000380062.5
ENST00000518614.1 |
IFT74
|
intraflagellar transport 74 homolog (Chlamydomonas) |
chr5_-_68628543 | 2.07 |
ENST00000396496.2
ENST00000511257.1 ENST00000383374.2 |
CCDC125
|
coiled-coil domain containing 125 |
chr10_+_114135004 | 2.04 |
ENST00000393081.1
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
chr6_+_39760129 | 2.00 |
ENST00000274867.4
|
DAAM2
|
dishevelled associated activator of morphogenesis 2 |
chr6_-_52705641 | 2.00 |
ENST00000370989.2
|
GSTA5
|
glutathione S-transferase alpha 5 |
chr1_+_182758900 | 1.89 |
ENST00000367555.1
ENST00000367554.3 |
NPL
|
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) |
chr1_-_108743471 | 1.86 |
ENST00000569674.1
|
SLC25A24
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 |
chr11_+_45907177 | 1.86 |
ENST00000241014.2
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1 |
chrX_+_105412290 | 1.84 |
ENST00000357175.2
ENST00000337685.2 |
MUM1L1
|
melanoma associated antigen (mutated) 1-like 1 |
chr17_-_7232585 | 1.81 |
ENST00000571887.1
ENST00000315614.7 ENST00000399464.2 ENST00000570460.1 |
NEURL4
|
neuralized E3 ubiquitin protein ligase 4 |
chrX_+_53449805 | 1.81 |
ENST00000414955.2
|
RIBC1
|
RIB43A domain with coiled-coils 1 |
chr2_+_98703643 | 1.80 |
ENST00000477737.1
|
VWA3B
|
von Willebrand factor A domain containing 3B |
chr10_+_118305435 | 1.78 |
ENST00000369221.2
|
PNLIP
|
pancreatic lipase |
chr1_-_85930246 | 1.77 |
ENST00000426972.3
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
chr4_-_70518941 | 1.75 |
ENST00000286604.4
ENST00000505512.1 ENST00000514019.1 |
UGT2A1
UGT2A1
|
UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus |
chr12_-_90024360 | 1.74 |
ENST00000393164.2
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1 |
chr14_+_77582905 | 1.74 |
ENST00000557408.1
|
TMEM63C
|
transmembrane protein 63C |
chr10_+_45406627 | 1.71 |
ENST00000389583.4
|
TMEM72
|
transmembrane protein 72 |
chr11_+_64073699 | 1.67 |
ENST00000405666.1
ENST00000468670.1 |
ESRRA
|
estrogen-related receptor alpha |
chr15_-_83316254 | 1.66 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
chr5_-_74807418 | 1.59 |
ENST00000405807.4
ENST00000261415.7 |
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein |
chr1_+_16062820 | 1.58 |
ENST00000294454.5
|
SLC25A34
|
solute carrier family 25, member 34 |
chr11_-_33913708 | 1.55 |
ENST00000257818.2
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr12_-_57443886 | 1.53 |
ENST00000300119.3
|
MYO1A
|
myosin IA |
chr7_-_138363824 | 1.52 |
ENST00000419765.3
|
SVOPL
|
SVOP-like |
chr20_+_44098346 | 1.50 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
chr19_-_50529193 | 1.44 |
ENST00000596445.1
ENST00000599538.1 |
VRK3
|
vaccinia related kinase 3 |
chr8_+_1993173 | 1.38 |
ENST00000523438.1
|
MYOM2
|
myomesin 2 |
chr7_-_100026280 | 1.38 |
ENST00000360951.4
ENST00000398027.2 ENST00000324725.6 ENST00000472716.1 |
ZCWPW1
|
zinc finger, CW type with PWWP domain 1 |
chr7_-_87849340 | 1.33 |
ENST00000419179.1
ENST00000265729.2 |
SRI
|
sorcin |
chr11_-_6440624 | 1.31 |
ENST00000311051.3
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
chr17_+_30771279 | 1.29 |
ENST00000261712.3
ENST00000578213.1 ENST00000457654.2 ENST00000579451.1 |
PSMD11
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
chr11_-_236326 | 1.26 |
ENST00000525237.1
ENST00000532956.1 ENST00000525319.1 ENST00000524564.1 ENST00000382743.4 |
SIRT3
|
sirtuin 3 |
chr11_+_17756279 | 1.26 |
ENST00000265969.6
|
KCNC1
|
potassium voltage-gated channel, Shaw-related subfamily, member 1 |
chr6_-_46922659 | 1.25 |
ENST00000265417.7
|
GPR116
|
G protein-coupled receptor 116 |
chr15_+_41913690 | 1.24 |
ENST00000563576.1
|
MGA
|
MGA, MAX dimerization protein |
chr20_+_44098385 | 1.24 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
chrX_-_132549506 | 1.21 |
ENST00000370828.3
|
GPC4
|
glypican 4 |
chr12_+_12202774 | 1.20 |
ENST00000589718.1
|
BCL2L14
|
BCL2-like 14 (apoptosis facilitator) |
chr12_+_12202785 | 1.20 |
ENST00000586576.1
ENST00000464885.2 |
BCL2L14
|
BCL2-like 14 (apoptosis facilitator) |
chr2_+_219247021 | 1.19 |
ENST00000539932.1
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 |
chr8_+_104831554 | 1.18 |
ENST00000408894.2
|
RIMS2
|
regulating synaptic membrane exocytosis 2 |
chr15_-_43559055 | 1.16 |
ENST00000220420.5
ENST00000349114.4 |
TGM5
|
transglutaminase 5 |
chr1_+_40840320 | 1.14 |
ENST00000372708.1
|
SMAP2
|
small ArfGAP2 |
chr11_+_129685707 | 1.14 |
ENST00000281441.3
|
TMEM45B
|
transmembrane protein 45B |
chr19_+_859425 | 1.13 |
ENST00000327726.6
|
CFD
|
complement factor D (adipsin) |
chr22_-_31688381 | 1.10 |
ENST00000487265.2
|
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr1_+_147013182 | 1.05 |
ENST00000234739.3
|
BCL9
|
B-cell CLL/lymphoma 9 |
chr6_+_167738569 | 1.04 |
ENST00000239587.5
|
TTLL2
|
tubulin tyrosine ligase-like family, member 2 |
chr1_-_1009683 | 1.04 |
ENST00000453464.2
|
RNF223
|
ring finger protein 223 |
chr16_-_81110683 | 1.04 |
ENST00000565253.1
ENST00000378611.4 ENST00000299578.5 |
C16orf46
|
chromosome 16 open reading frame 46 |
chr14_-_76447494 | 1.03 |
ENST00000238682.3
|
TGFB3
|
transforming growth factor, beta 3 |
chr11_+_61447845 | 1.03 |
ENST00000257215.5
|
DAGLA
|
diacylglycerol lipase, alpha |
chr11_+_65266507 | 1.02 |
ENST00000544868.1
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
chr6_-_13487825 | 1.02 |
ENST00000603223.1
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1 |
chr16_+_53133070 | 1.02 |
ENST00000565832.1
|
CHD9
|
chromodomain helicase DNA binding protein 9 |
chr11_-_76155700 | 1.01 |
ENST00000572035.1
|
RP11-111M22.3
|
RP11-111M22.3 |
chr11_-_114271139 | 1.00 |
ENST00000325636.4
|
C11orf71
|
chromosome 11 open reading frame 71 |
chr15_+_67547163 | 0.98 |
ENST00000335894.4
|
IQCH
|
IQ motif containing H |
chr19_+_859654 | 0.98 |
ENST00000592860.1
|
CFD
|
complement factor D (adipsin) |
chr5_+_98104978 | 0.97 |
ENST00000308234.7
|
RGMB
|
repulsive guidance molecule family member b |
chr12_-_107380910 | 0.97 |
ENST00000392830.2
ENST00000240050.4 |
MTERFD3
|
MTERF domain containing 3 |
chr1_+_155099927 | 0.97 |
ENST00000368407.3
|
EFNA1
|
ephrin-A1 |
chr6_+_131894284 | 0.96 |
ENST00000368087.3
ENST00000356962.2 |
ARG1
|
arginase 1 |
chr10_+_695888 | 0.96 |
ENST00000441152.2
|
PRR26
|
proline rich 26 |
chr4_+_74735102 | 0.94 |
ENST00000395761.3
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
chr17_+_76311791 | 0.94 |
ENST00000586321.1
|
AC061992.2
|
AC061992.2 |
chr11_-_133826852 | 0.93 |
ENST00000533871.2
ENST00000321016.8 |
IGSF9B
|
immunoglobulin superfamily, member 9B |
chr15_-_52030293 | 0.92 |
ENST00000560491.1
ENST00000267838.3 |
LYSMD2
|
LysM, putative peptidoglycan-binding, domain containing 2 |
chr2_-_152146385 | 0.92 |
ENST00000414946.1
ENST00000243346.5 |
NMI
|
N-myc (and STAT) interactor |
chr3_-_46505137 | 0.91 |
ENST00000426532.2
ENST00000415180.1 |
LTF
|
lactotransferrin |
chr12_-_107380846 | 0.91 |
ENST00000548101.1
ENST00000550496.1 ENST00000552029.1 |
MTERFD3
|
MTERF domain containing 3 |
chr14_-_65569244 | 0.90 |
ENST00000557277.1
ENST00000556892.1 |
MAX
|
MYC associated factor X |
chr1_-_115124257 | 0.89 |
ENST00000369541.3
|
BCAS2
|
breast carcinoma amplified sequence 2 |
chr6_-_154751629 | 0.88 |
ENST00000424998.1
|
CNKSR3
|
CNKSR family member 3 |
chr1_-_44818599 | 0.88 |
ENST00000537474.1
|
ERI3
|
ERI1 exoribonuclease family member 3 |
chr12_-_91576429 | 0.88 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
chr11_-_44972476 | 0.87 |
ENST00000527685.1
ENST00000308212.5 |
TP53I11
|
tumor protein p53 inducible protein 11 |
chr2_-_61697862 | 0.86 |
ENST00000398571.2
|
USP34
|
ubiquitin specific peptidase 34 |
chr6_-_84937314 | 0.85 |
ENST00000257766.4
ENST00000403245.3 |
KIAA1009
|
KIAA1009 |
chr3_-_146213722 | 0.84 |
ENST00000336685.2
ENST00000489015.1 |
PLSCR2
|
phospholipid scramblase 2 |
chr12_+_58148842 | 0.84 |
ENST00000266643.5
|
MARCH9
|
membrane-associated ring finger (C3HC4) 9 |
chr22_-_31688431 | 0.83 |
ENST00000402249.3
ENST00000443175.1 ENST00000215912.5 ENST00000441972.1 |
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr22_-_24110063 | 0.83 |
ENST00000520222.1
ENST00000401675.3 |
CHCHD10
|
coiled-coil-helix-coiled-coil-helix domain containing 10 |
chrX_-_19689106 | 0.83 |
ENST00000379716.1
|
SH3KBP1
|
SH3-domain kinase binding protein 1 |
chr18_-_30050395 | 0.82 |
ENST00000269209.6
ENST00000399218.4 |
GAREM
|
GRB2 associated, regulator of MAPK1 |
chr20_-_271009 | 0.82 |
ENST00000382369.5
|
C20orf96
|
chromosome 20 open reading frame 96 |
chr14_+_32546274 | 0.82 |
ENST00000396582.2
|
ARHGAP5
|
Rho GTPase activating protein 5 |
chr3_-_52443799 | 0.80 |
ENST00000470173.1
ENST00000296288.5 |
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) |
chr4_+_160188889 | 0.79 |
ENST00000264431.4
|
RAPGEF2
|
Rap guanine nucleotide exchange factor (GEF) 2 |
chr3_-_49466686 | 0.78 |
ENST00000273598.3
ENST00000436744.2 |
NICN1
|
nicolin 1 |
chr2_-_40679186 | 0.78 |
ENST00000406785.2
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1 |
chr15_+_60296421 | 0.78 |
ENST00000396057.4
|
FOXB1
|
forkhead box B1 |
chr17_+_58755184 | 0.78 |
ENST00000589222.1
ENST00000407086.3 ENST00000390652.5 |
BCAS3
|
breast carcinoma amplified sequence 3 |
chr17_-_42452063 | 0.78 |
ENST00000588098.1
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
chr2_+_217498105 | 0.77 |
ENST00000233809.4
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa |
chr3_-_61237050 | 0.77 |
ENST00000476844.1
ENST00000488467.1 ENST00000492590.1 ENST00000468189.1 |
FHIT
|
fragile histidine triad |
chrX_-_10645773 | 0.76 |
ENST00000453318.2
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr1_+_174843548 | 0.74 |
ENST00000478442.1
ENST00000465412.1 |
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr12_+_32112340 | 0.73 |
ENST00000540924.1
ENST00000312561.4 |
KIAA1551
|
KIAA1551 |
chr19_-_10213335 | 0.73 |
ENST00000592641.1
ENST00000253109.4 |
ANGPTL6
|
angiopoietin-like 6 |
chr17_-_20370847 | 0.72 |
ENST00000423676.3
ENST00000324290.5 |
LGALS9B
|
lectin, galactoside-binding, soluble, 9B |
chr1_+_27114418 | 0.72 |
ENST00000078527.4
|
PIGV
|
phosphatidylinositol glycan anchor biosynthesis, class V |
chr11_-_76155618 | 0.72 |
ENST00000530759.1
|
RP11-111M22.3
|
RP11-111M22.3 |
chr1_+_26146397 | 0.70 |
ENST00000374303.2
ENST00000533762.1 ENST00000529116.1 ENST00000474295.1 ENST00000488327.2 ENST00000472643.1 ENST00000526894.1 ENST00000524618.1 ENST00000374307.5 |
MTFR1L
|
mitochondrial fission regulator 1-like |
chr19_+_3721719 | 0.70 |
ENST00000589378.1
ENST00000382008.3 |
TJP3
|
tight junction protein 3 |
chr5_+_74807581 | 0.70 |
ENST00000241436.4
ENST00000352007.5 |
POLK
|
polymerase (DNA directed) kappa |
chr3_+_142315225 | 0.70 |
ENST00000457734.2
ENST00000483373.1 ENST00000475296.1 ENST00000495744.1 ENST00000476044.1 ENST00000461644.1 |
PLS1
|
plastin 1 |
chr16_-_88717482 | 0.69 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
chr21_+_25801041 | 0.69 |
ENST00000453784.2
ENST00000423581.1 |
AP000476.1
|
AP000476.1 |
chrX_+_18443703 | 0.69 |
ENST00000379996.3
|
CDKL5
|
cyclin-dependent kinase-like 5 |
chr2_-_175869936 | 0.68 |
ENST00000409900.3
|
CHN1
|
chimerin 1 |
chr4_-_89619386 | 0.67 |
ENST00000323061.5
|
NAP1L5
|
nucleosome assembly protein 1-like 5 |
chr1_+_26146674 | 0.66 |
ENST00000525713.1
ENST00000374301.3 |
MTFR1L
|
mitochondrial fission regulator 1-like |
chr16_-_88717423 | 0.66 |
ENST00000568278.1
ENST00000569359.1 ENST00000567174.1 |
CYBA
|
cytochrome b-245, alpha polypeptide |
chr17_-_9929581 | 0.66 |
ENST00000437099.2
ENST00000396115.2 |
GAS7
|
growth arrest-specific 7 |
chr17_+_25958174 | 0.66 |
ENST00000313648.6
ENST00000577392.1 ENST00000584661.1 ENST00000413914.2 |
LGALS9
|
lectin, galactoside-binding, soluble, 9 |
chr10_-_65028938 | 0.66 |
ENST00000402544.1
|
JMJD1C
|
jumonji domain containing 1C |
chr19_+_1000418 | 0.66 |
ENST00000234389.3
|
GRIN3B
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
chr7_+_107110488 | 0.65 |
ENST00000304402.4
|
GPR22
|
G protein-coupled receptor 22 |
chr12_-_10151773 | 0.65 |
ENST00000298527.6
ENST00000348658.4 |
CLEC1B
|
C-type lectin domain family 1, member B |
chr22_+_35776828 | 0.63 |
ENST00000216117.8
|
HMOX1
|
heme oxygenase (decycling) 1 |
chr17_-_1553346 | 0.62 |
ENST00000301336.6
|
RILP
|
Rab interacting lysosomal protein |
chr9_-_35815013 | 0.62 |
ENST00000259667.5
|
HINT2
|
histidine triad nucleotide binding protein 2 |
chr5_+_140207536 | 0.62 |
ENST00000529310.1
ENST00000527624.1 |
PCDHA6
|
protocadherin alpha 6 |
chr14_-_20881579 | 0.62 |
ENST00000556935.1
ENST00000262715.5 ENST00000556549.1 |
TEP1
|
telomerase-associated protein 1 |
chr8_+_28351707 | 0.61 |
ENST00000537916.1
ENST00000523546.1 ENST00000240093.3 |
FZD3
|
frizzled family receptor 3 |
chr15_-_83316087 | 0.61 |
ENST00000568757.1
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
chr10_-_65028817 | 0.60 |
ENST00000542921.1
|
JMJD1C
|
jumonji domain containing 1C |
chr10_-_120355149 | 0.60 |
ENST00000239032.2
|
PRLHR
|
prolactin releasing hormone receptor |
chr13_+_42031679 | 0.59 |
ENST00000379359.3
|
RGCC
|
regulator of cell cycle |
chr2_+_74648848 | 0.59 |
ENST00000409791.1
ENST00000426787.1 ENST00000348227.4 |
WDR54
|
WD repeat domain 54 |
chr4_+_154622652 | 0.59 |
ENST00000260010.6
|
TLR2
|
toll-like receptor 2 |
chr19_+_50529212 | 0.59 |
ENST00000270617.3
ENST00000445728.3 ENST00000601364.1 |
ZNF473
|
zinc finger protein 473 |
chr5_-_34043310 | 0.58 |
ENST00000231338.7
|
C1QTNF3
|
C1q and tumor necrosis factor related protein 3 |
chr9_-_117150303 | 0.58 |
ENST00000312033.3
|
AKNA
|
AT-hook transcription factor |
chr12_-_56120838 | 0.57 |
ENST00000548160.1
|
CD63
|
CD63 molecule |
chr12_-_81763127 | 0.57 |
ENST00000541017.1
|
PPFIA2
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
chr9_+_134378289 | 0.56 |
ENST00000423007.1
ENST00000404875.2 ENST00000441334.1 ENST00000341012.7 ENST00000372228.3 ENST00000402686.3 ENST00000419118.2 ENST00000541219.1 ENST00000354713.4 ENST00000418774.1 ENST00000415075.1 ENST00000448212.1 ENST00000430619.1 |
POMT1
|
protein-O-mannosyltransferase 1 |
chr8_-_27457494 | 0.56 |
ENST00000521770.1
|
CLU
|
clusterin |
chr6_+_30295036 | 0.56 |
ENST00000376659.5
ENST00000428555.1 |
TRIM39
|
tripartite motif containing 39 |
chr5_-_145562147 | 0.55 |
ENST00000545646.1
ENST00000274562.9 ENST00000510191.1 ENST00000394434.2 |
LARS
|
leucyl-tRNA synthetase |
chr4_+_108745711 | 0.55 |
ENST00000394684.4
|
SGMS2
|
sphingomyelin synthase 2 |
chr17_+_76356516 | 0.55 |
ENST00000592569.1
|
RP11-806H10.4
|
RP11-806H10.4 |
chr6_+_108487245 | 0.55 |
ENST00000368986.4
|
NR2E1
|
nuclear receptor subfamily 2, group E, member 1 |
chr19_+_50528971 | 0.55 |
ENST00000598809.1
ENST00000595661.1 ENST00000391821.2 |
ZNF473
|
zinc finger protein 473 |
chr22_-_41215328 | 0.54 |
ENST00000434185.1
ENST00000435456.2 |
SLC25A17
|
solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17 |
chr19_-_36236292 | 0.53 |
ENST00000378975.3
ENST00000412391.2 ENST00000292879.5 |
U2AF1L4
|
U2 small nuclear RNA auxiliary factor 1-like 4 |
chr12_-_81763184 | 0.53 |
ENST00000548670.1
ENST00000541570.2 ENST00000553058.1 |
PPFIA2
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
chr1_+_32716840 | 0.53 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr5_+_56469843 | 0.53 |
ENST00000514387.2
|
GPBP1
|
GC-rich promoter binding protein 1 |
chr6_+_160221293 | 0.52 |
ENST00000610273.1
ENST00000392167.3 |
PNLDC1
|
poly(A)-specific ribonuclease (PARN)-like domain containing 1 |
chr7_-_91875358 | 0.51 |
ENST00000458177.1
ENST00000394507.1 ENST00000340022.2 ENST00000444960.1 |
KRIT1
|
KRIT1, ankyrin repeat containing |
chr12_-_91348949 | 0.50 |
ENST00000358859.2
|
CCER1
|
coiled-coil glutamate-rich protein 1 |
chr20_+_2517253 | 0.50 |
ENST00000358864.1
|
TMC2
|
transmembrane channel-like 2 |
chr8_-_72268968 | 0.49 |
ENST00000388740.3
|
EYA1
|
eyes absent homolog 1 (Drosophila) |
chr4_+_26322185 | 0.49 |
ENST00000361572.6
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
chr3_+_185000729 | 0.48 |
ENST00000448876.1
ENST00000446828.1 ENST00000447637.1 ENST00000424227.1 ENST00000454237.1 |
MAP3K13
|
mitogen-activated protein kinase kinase kinase 13 |
chr6_+_127588020 | 0.48 |
ENST00000309649.3
ENST00000610162.1 ENST00000610153.1 ENST00000608991.1 ENST00000480444.1 |
RNF146
|
ring finger protein 146 |
chr19_+_44081344 | 0.47 |
ENST00000599207.1
|
PINLYP
|
phospholipase A2 inhibitor and LY6/PLAUR domain containing |
chrX_+_129473859 | 0.47 |
ENST00000424447.1
|
SLC25A14
|
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
chr6_+_30294612 | 0.47 |
ENST00000440271.1
ENST00000396551.3 ENST00000376656.4 ENST00000540416.1 ENST00000428728.1 ENST00000396548.1 ENST00000428404.1 |
TRIM39
|
tripartite motif containing 39 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 9.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.9 | 2.7 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.8 | 2.5 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.6 | 2.3 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.5 | 1.6 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.5 | 1.5 | GO:0055073 | cadmium ion homeostasis(GO:0055073) divalent metal ion export(GO:0070839) |
0.5 | 4.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.5 | 3.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.4 | 2.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.4 | 1.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.4 | 1.9 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 1.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.3 | 2.3 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.3 | 1.0 | GO:0042704 | detection of oxygen(GO:0003032) uterine wall breakdown(GO:0042704) |
0.3 | 1.0 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.3 | 1.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 0.9 | GO:1905068 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.3 | 0.9 | GO:1900159 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
0.3 | 6.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 0.8 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 1.0 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
0.2 | 1.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 3.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.2 | 0.7 | GO:0043132 | coenzyme A transport(GO:0015880) FAD transport(GO:0015883) coenzyme A transmembrane transport(GO:0035349) FAD transmembrane transport(GO:0035350) NAD transport(GO:0043132) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.2 | 1.7 | GO:1990034 | cellular response to corticosterone stimulus(GO:0071386) calcium ion export from cell(GO:1990034) |
0.2 | 1.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.6 | GO:0006788 | heme oxidation(GO:0006788) smooth muscle hyperplasia(GO:0014806) negative regulation of mast cell cytokine production(GO:0032764) |
0.2 | 0.6 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.2 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.2 | 0.6 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.2 | 0.8 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 0.6 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 0.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
0.2 | 1.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 1.0 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 0.6 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.2 | 0.9 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.5 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.2 | 0.5 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.2 | 1.3 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 4.9 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 2.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 1.0 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 5.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 1.9 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 1.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 3.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 1.1 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 10.6 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 3.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.8 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.1 | 0.4 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
0.1 | 0.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 1.3 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.6 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.5 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.1 | 0.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.1 | 3.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.3 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.1 | 1.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 13.1 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.1 | 1.8 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.6 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.1 | 2.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 1.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 1.1 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 2.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 1.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 1.9 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 2.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 1.6 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.2 | GO:2000078 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) positive regulation of type B pancreatic cell development(GO:2000078) |
0.1 | 0.2 | GO:0043449 | olfactory learning(GO:0008355) cellular alkene metabolic process(GO:0043449) |
0.1 | 0.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.9 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 2.0 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.4 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.2 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.1 | 0.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 1.5 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 1.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.3 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.1 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 0.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 0.4 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 1.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.5 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.0 | 1.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.7 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 1.0 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.2 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.0 | 0.5 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.6 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.3 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.2 | GO:1903788 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.0 | 0.3 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.0 | 0.2 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.9 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.7 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 1.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.7 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.0 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.0 | 0.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.0 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 3.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.2 | GO:0034378 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) chylomicron assembly(GO:0034378) |
0.0 | 0.4 | GO:0055123 | digestive system development(GO:0055123) |
0.0 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.0 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.0 | 0.4 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.0 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.0 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.9 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 2.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.7 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:0045066 | regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 0.0 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.0 | 0.0 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.0 | 0.2 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 1.0 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.0 | 0.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.1 | GO:0021510 | spinal cord development(GO:0021510) |
0.0 | 0.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 0.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.2 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) |
0.0 | 0.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.6 | 6.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 26.8 | GO:0030286 | dynein complex(GO:0030286) |
0.3 | 2.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 0.8 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.2 | 0.6 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.2 | 1.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 1.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.2 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 4.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 4.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.0 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.9 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 1.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 2.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 4.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.0 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 2.1 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.4 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 1.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 1.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 5.2 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 6.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 2.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 1.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 1.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 3.1 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 3.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.8 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.4 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 10.9 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 3.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 1.1 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 4.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 1.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 26.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.6 | 1.9 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.5 | 1.5 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.5 | 2.7 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.5 | 2.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 4.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 4.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 2.3 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.3 | 1.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 1.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 0.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.3 | 1.8 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.2 | 1.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.2 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.2 | 5.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.7 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) FAD transmembrane transporter activity(GO:0015230) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.2 | 3.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.6 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 0.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 3.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.6 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.2 | 0.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 2.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.7 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 1.9 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 0.7 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.4 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.1 | 3.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 1.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.4 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.1 | 1.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 2.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.8 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.5 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 2.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 1.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 2.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.3 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 0.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 3.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 0.9 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 1.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.4 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
0.1 | 1.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 2.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 1.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.2 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.1 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.9 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.3 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 1.0 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.0 | 1.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 4.5 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.3 | GO:0031730 | CCR1 chemokine receptor binding(GO:0031726) CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 2.4 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 1.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 2.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.5 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 1.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 1.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 1.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.9 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.0 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 1.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.0 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.0 | 2.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 3.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.0 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 1.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 1.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.6 | GO:0030295 | protein kinase activator activity(GO:0030295) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 14.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 6.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 2.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 1.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 2.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 5.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 4.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.0 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 6.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 5.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 2.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 2.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 2.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 2.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 2.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 3.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 2.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 3.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 2.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 7.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 3.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 1.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 2.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.6 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |